Atlas Trials

Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male Subjects

Clinical trial NCT05110118 · COMPLETED

Trial details

NCT number
NCT05110118
Sponsor
Shandong Boan Biotechnology Co., Ltd
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Colorectal CancerNon Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Recurrent
Start date
2020-08-04
Primary completion
2021-01-13
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.